These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 19402061)

  • 21. [Focal nodular hepatic hyperplasia].
    Shchegolev AI; Tin'kova IO; Mishnev OD; Vtiurin BV; Paklina OV
    Arkh Patol; 2004; 66(3):42-4. PubMed ID: 15318557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glypican-3 as a serum marker for hepatocellular carcinoma.
    Capurro M; Filmus J
    Cancer Res; 2005 Jan; 65(1):372; author reply 372-3. PubMed ID: 15665316
    [No Abstract]   [Full Text] [Related]  

  • 23. Molecular markers and hepatocellular carcinoma: lending a helping hand in liver transplantation?
    Dai Z; Yu L; Zhou J; Qiu SJ; Fan J
    Expert Rev Gastroenterol Hepatol; 2009 Jun; 3(3):211-3. PubMed ID: 19485802
    [No Abstract]   [Full Text] [Related]  

  • 24. Role and significance of focal adhesion proteins in hepatocellular carcinoma.
    Yam JW; Tse EY; Ng IO
    J Gastroenterol Hepatol; 2009 Apr; 24(4):520-30. PubMed ID: 19368632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
    Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
    Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The relationship between benign liver tumors and free radicals].
    Váli L; Szijártó A; Hahn O; Fehér J; Kupcsulik P
    Orv Hetil; 2004 Oct; 145(40):2043-50. PubMed ID: 15559531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory hepatocellular adenoma, focal nodular hyperplasia and hepatic granulomas in one single patient : possible physiopathologic explanations.
    Dehon R; Scagnol I; Komuta M; Gomez-Galdon M; Demetter P
    Acta Gastroenterol Belg; 2020; 83(1):83-85. PubMed ID: 32233277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokeratin 8/18 as a new marker of mouse liver preneoplastic lesions.
    Kakehashi A; Kato A; Inoue M; Ishii N; Okazaki E; Wei M; Tachibana T; Wanibuchi H
    Toxicol Appl Pharmacol; 2010 Jan; 242(1):47-55. PubMed ID: 19796649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fascin expression in progression and prognosis of hepatocellular carcinoma.
    Iguchi T; Aishima S; Umeda K; Sanefuji K; Fujita N; Sugimachi K; Gion T; Taketomi A; Maehara Y; Tsuneyoshi M
    J Surg Oncol; 2009 Dec; 100(7):575-9. PubMed ID: 19697358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatobiliary and pancreatic: Hepatic adenoma, focal nodular hyperplasia and congenital absence of the portal vein.
    Koizumi J; Yamashita T; Dowaki S; Tobita K; Shimamura K; Hirabayashi K; Imai Y; Imaizumi T
    J Gastroenterol Hepatol; 2006 Mar; 21(3):619. PubMed ID: 16638111
    [No Abstract]   [Full Text] [Related]  

  • 31. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
    Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma.
    Rebouissou S; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2008 Jan; 48(1):163-70. PubMed ID: 17997499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
    Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
    Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
    Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update.
    Bioulac-Sage P; Balabaud C; Bedossa P; Scoazec JY; Chiche L; Dhillon AP; Ferrell L; Paradis V; Roskams T; Vilgrain V; Wanless IR; Zucman-Rossi J;
    J Hepatol; 2007 Mar; 46(3):521-7. PubMed ID: 17239484
    [No Abstract]   [Full Text] [Related]  

  • 36. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
    Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
    Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histochemical demonstration of estradiol receptors in primary liver cancers].
    Deugnier Y; Ramée MP; Campion JP; Messner M; Launois B; Bourel M; Ferrand B
    Gastroenterol Clin Biol; 1983 Oct; 7(10):828-9. PubMed ID: 6313463
    [No Abstract]   [Full Text] [Related]  

  • 38. Serum Golgi Phosphoprotein 2 level: a better marker than alpha-fetoprotein for diagnosing early hepatocellular carcinoma.
    Li X; Wu K; Fan D
    Hepatology; 2009 Jul; 50(1):325. PubMed ID: 19492428
    [No Abstract]   [Full Text] [Related]  

  • 39. Glypican-3: a novel diagnostic marker for hepatocellular carcinoma and more.
    Kandil DH; Cooper K
    Adv Anat Pathol; 2009 Mar; 16(2):125-9. PubMed ID: 19550373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular glycogenosis and hepatic neoplasms.
    Bannasch P
    Toxicol Pathol; 2010 Oct; 38(6):1000-2. PubMed ID: 21037203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.